{"certainAgreement":{"otherDetails":"Investigator agrees not to independently publish the results of the Study until first occurrence of one of the following: (i) multi-centre primary Publication is published; (ii) no multi-centre primary publication is submitted within two years after conclusion, abandonment, or termination of the Study at all sites; or (iii) Sponsor confirms in writing there will be no multi-centre primary Publication.","piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true},"pointOfContact":{"email":"information.center@astrazeneca.com","organization":"AstraZeneca Clinical Study Information Center","phone":"1 8772409479","title":"Global Clinical Lead"}}